Target Gene/Pathway Pathway / Gene
Search results
Showing 1 to 10 of 96 entries
| No. | KEGG GENES | KEGG PATHWAY | KEGG DRUG | DrugBank | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
PDE10A
💬1. PDE10A
| 4件: Purine metabolism Purine metabolism, Metabolic pathways, cAMP signaling pathway, Morphine addiction | Flavoxate
Flavoxate
💬1. PDE10A
| Flavoxate | 1件: 226 226 💬1. PDE10A
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 |
CHRM1
💬2. CHRM1
| 8件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Cholinergic synapse, Regulation of actin cytoskeleton, Alzheimer disease, Pathways of neurodegeneration - multiple diseases 8件: Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, PI3K ... | Propiverine
Propiverine
💬2. CHRM1
| Propiverine | 1件: 226 226 💬2. CHRM1
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 |
CHRM2
💬3. CHRM2
| 6件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Cholinergic synapse, Regulation of actin cytoskeleton 6件: Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, PI3K ... | Propiverine
Propiverine
💬3. CHRM2
| Propiverine | 1件: 226 226 💬3. CHRM2
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 |
CHRM3
💬4. CHRM3
| 11件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Cholinergic synapse, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Alzheimer disease, Pathways of neurodegeneration - multiple diseases 11件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Cholinergic synapse, Taste ... | Propiverine
Propiverine
💬4. CHRM3
| Propiverine | 1件: 226 226 💬4. CHRM3
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 |
CHRM4
💬5. CHRM4
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Cholinergic synapse, Regulation of actin cytoskeleton | Propiverine
Propiverine
💬5. CHRM4
| Propiverine | 1件: 226 226 💬5. CHRM4
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 |
CHRM5
💬6. CHRM5
| 6件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Cholinergic synapse, Regulation of actin cytoskeleton, Alzheimer disease, Pathways of neurodegeneration - multiple diseases 6件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Cholinergic synapse, Regulat ... | Propiverine
Propiverine
💬6. CHRM5
| Propiverine | 1件: 226 226 💬6. CHRM5
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 |
CNR1
💬7. CNR1
| 4件: Rap1 signaling pathway Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Thermogenesis, Retrograde endocannabinoid signaling 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Thermogenesis, Retrograde endoc ... | Cannabidiol
Cannabidiol
💬7. CNR1
| Cannabidiol | 20件: 2 2, 6, 8, 13, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬7. CNR1
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 |
CNR2
💬8. CNR2
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Cannabidiol
Cannabidiol
💬8. CNR2
| Cannabidiol | 20件: 2 2, 6, 8, 13, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬8. CNR2
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 |
ADRA2A
💬9. ADRA2A
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Dexmedetomidine
Dexmedetomidine
💬9. ADRA2A
| Dexmedetomidine | 14件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬9. ADRA2A
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 |
ADRA2B
💬10. ADRA2B
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Dexmedetomidine
Dexmedetomidine
💬10. ADRA2B
| Dexmedetomidine | 14件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬10. ADRA2B
|